Behind the Mystery: Understanding Pheochromocytoma and Paraganglioma
February 28, 2019
Learn About Pheochromocytoma and Paraganglioma, Known As Rare Neuroendocrine Tumors
Understanding Pheochromocytoma and Paraganglioma; rare neuroendocrine tumors that can dramatically impact survival in people of all ages. Every year in the US, fewer than 8 out of one million people are diagnosed with pheo or para tumors. But as many as 130,000 people are living with the disease in the US, although that number may be higher due to underdiagnosis. If pheo and para tumors are not diagnosed and appropriately treated, the disease will likely be fatal Dr. Joseph Dillon, Co-Director of the Neuroendocrine Tumor Clinic at the University of Iowa educates us on these rare tumors, symptoms to be aware of, and how patients should proceed if they are diagnosed.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.